SBI Securities’s Marker Therapeutics MRKR Stock Holding History

SBI Securities’s Portfolio MRKR Stock Details MRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$298	Hold	203	–	–	﹤0.01%	3202
2026 Q1	$264	Hold	203	–	–	﹤0.01%	3119
2025 Q4	$302	Hold	203	–	–	﹤0.01%	3065
2025 Q3	$181	Sell	203 -1,500	-88%	-$1.85K	﹤0.01%	3351
2025 Q2	$2.61K	Buy	1,703 +500	+42%	+$642	﹤0.01%	2280
2025 Q1	$1.48K	Buy	1,203 +1,001	+496%	+$1.83K	﹤0.01%	2423
2024 Q4	$628	Buy	+202	New	+$715	﹤0.01%	2814

Other funds holding MRKR

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

HNB

Hilltop National Bank Casper, Wyoming $468M AUM 36.09% 1-Year Est. Return

SBI Securities's MRKR Position: Q2 2026 in Review

SBI Securities held its Marker Therapeutics (MRKR) position steady in Q2 2026 at 203 shares worth $298. The position accounts for ﹤0.01% of the portfolio, ranked #3202.

SBI Securities first reported a position in MRKR in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.61K in Q2 2025. 3 funds tracked by Wall St. Rank hold MRKR as of Q2 2026.

SBI Securities held 203 shares of Marker Therapeutics worth $298 as of Q2 2026.
SBI Securities left its Marker Therapeutics share count unchanged in Q2 2026.
Marker Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3202 holding.
SBI Securities first reported a position in Marker Therapeutics in Q4 2024 and has held it in 7 quarters since.
SBI Securities's Marker Therapeutics position peaked at $2.61K in Q2 2025.
3 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.